Immunochromatography test strip for quantitatively detecting CRP (C-reactive protein), preparation method of immunochromatography test strip and coating buffer solution
The lack of sensitivity and accuracy of C-reactive protein detection by using buffer, sugar and reduced glutathione-coated buffer is solved by using buffer, sugar and reducing glutathione-coated buffer to coat CRP-specific antibodies in fluorescent immunochromatography test strips. The problem of this method achieves higher detection precision and lower interference, improving the performance of the test strip.
Patent Information
- Application Number
- CN202411241883.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-05
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-09-05
AI Technical Summary
Fluorescent immunochromatography technology has low sensitivity and accuracy in detection of C-reactive protein, especially when the concentration changes violently, which affects the determination of results.
Coating buffer containing buffer, sugars, alcohols and reduced glutathione is used to coat CRP-specific antibodies to form detection bands, and the sensitivity and accuracy of detection are improved by reducing glutathione. , reduce sample interference.
It improves the detection sensitivity and accuracy of C-reactive protein, reduces batch differences, enhances the performance of test strips, and performs better especially when low concentration and high value samples are detected.
Smart Images

Figure CN119023950A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of detection reagents, and in particular to an immunochromatographic test strip for quantitatively detecting CRP, a preparation method thereof, and a coating buffer. Background Art
[0002] C-reactive protein (CRP) is a protein (acute protein) that rises sharply in plasma when the body is infected or the tissue is damaged. It activates complement and strengthens the phagocytosis of phagocytes to play a conditioning role, clearing pathogenic microorganisms that invade the body and damaged, necrotic, and apoptotic tissue cells. C-reactive protein is a pentamer composed of 5 identical non-glycosylated subunits non-covalently linked, and a disulfide bond is formed between cysteine at positions 36 and 97 in each subunit. The concentration of C-reactive protein in plasma is extremely low in normal people, but it increases significantly when cells are infected and tissues are damaged, and the rise and fall are very rapid. It is one of the preferred indicators for judging the degree of acute inflammatory tissue damage and the effect of treatment, and is widely used in the differential diagnosis of clinical diseases.
[0003] Fluorescent immunochromatography is a quantitative analysis method developed at the end of the 20th century that combines immunochromatography and fluorescence detection technology. It is simple to operate, fast, and has low requirements for the laboratory environment. It is suitable for some application scenarios that require rapid test results. However, compared with new detection technologies such as chemiluminescence and molecular diagnosis, fluorescent immunochromatography has the problems of poor sensitivity and difficulty in quantification, especially for the detection of substances such as C-reactive protein, whose concentration changes very drastically. The sensitivity and accuracy of the test have a great influence on the determination of the results. Therefore, how to improve the sensitivity and accuracy of C-reactive protein immunochromatography strips is a problem that needs to be solved urgently by technicians in this field. Summary of the invention
[0004] To solve the above technical problems, the first purpose of the present invention is to provide a coating buffer for an immunochromatographic test strip for quantitative detection of CRP; the second purpose of the present invention is to provide a method for preparing an immunochromatographic test strip for quantitative detection of CRP; the third purpose of the present invention is to provide an immunochromatographic test strip for quantitative detection of CRP. The coating buffer and test strip provided in this application can improve the detection sensitivity of CRP and reduce interference, improve precision, improve product performance, and help control batch differences.
[0005] The technical solution provided by the present invention is as follows: A coating buffer for an immunochromatographic test strip for quantitatively detecting CRP comprises a buffer, sugars, and alcohol reduced glutathione.
[0006] Preferably, the mass percentage concentration of reduced glutathione is 0.05-0.5%.
[0007] Preferably, the buffer concentration is 0.01-0.1 mol / L; The mass percentage concentration of sugars is 0.5-5%; The mass percentage concentration of alcohols is 0.1-2%.
[0008] Preferably, the buffer is any one of tris-hydroxyaminomethane buffer, 4-hydroxyethylpiperazineethanesulfonic acid, phosphate buffer, and borate buffer; The sugar is any one or more of trehalose, sucrose, lactose and dextran; The alcohol is any one or more of isopropanol, methanol, and ethanol.
[0009] Preferably, the preservative is also included in a mass percentage concentration of 0.01-0.1%. Preferably, the preservative is any one or more of sodium azide, PC300, potassium sorbate, and Krovin300M.
[0010] A method for preparing an immunochromatographic test strip for quantitatively detecting CRP, wherein the detection strip is formed by coating a CRP-specific antibody using any of the coating buffers described above.
[0011] Preferably, the method comprises the following steps: S1, applying CRP-specific antibody A coupled to fluorescent microspheres and quality control antibody A coupled to fluorescent microspheres to the conjugate pad; S2. Coating the CRP-specific antibody B on the reaction membrane using any of the coating buffers described above to form a detection zone; The quality control antibody B is coated on the reaction membrane to form a quality control band; S3, assembling the sample pad, the binding pad prepared in step S1, the reaction membrane prepared in step S2, and the water absorbent pad onto the bottom plate to obtain a test strip; There is no order restriction for steps S1 and S2.
[0012] Preferably, in step S2, the CRP-specific antibody B is diluted to 0.5-1.5 mg / L using the coating buffer described in any one of claims 1-6, coated on the reaction membrane, and then dried at 50-60° C. for 65-80 h.
[0013] An immunochromatographic test strip for quantitative detection of CRP prepared by any of the preparation methods described above.
[0014] C-reactive protein (CRP) exists in the human body as a pentamer and needs to be reduced to a monomer before it can be detected. This application improves the sensitivity of CRP detection by adding reduced glutathione to the coating buffer of the immunochromatographic test strip used for quantitative detection of CRP. The specific reasons are as follows: First, inflammatory samples often contain higher concentrations of hydrogen peroxide. Reduced glutathione can offset some of the oxidative substances in the samples, preventing them from affecting specific antigen-antibody binding, and helping to reduce interference in samples with high CRP values.
[0015] Second, CRP exists in the human body in the form of pentamers, and the CRP produced in the human body needs to be reduced to monomers before it can be detected. Reduced glutathione can participate in this process, so that the CRP in the sample can be dissociated into monomers when passing through the detection line, which is beneficial to signal enhancement and makes the CRP in the sample easier to detect.
[0016] Third, the characteristics of CRP chromatography test strips are short reaction time and solid phase carrier reaction. Compared with liquid phase reaction, the contact time between the sample to be tested and the antibody is short. Therefore, adding reduced glutathione can facilitate rapid reaction in a short time and help improve sensitivity.
[0017] The coating buffer provided in the present application contains a buffer, sugars, alcohols and reduced glutathione.
[0018] Preferably, the mass percentage concentration of reduced glutathione in the coating buffer is 0.05-0.5%.
[0019] Preferably, the concentration of the buffer in the coating buffer is 0.01-0.1 mol / L; the mass percentage concentration of the sugar is 0.5-5%; the mass percentage concentration of the alcohol is 0.1-2%. The buffer is any one of trishydroxyaminomethane buffer, 4-hydroxyethylpiperazineethanesulfonic acid, phosphate buffer, and borate buffer; the sugar is any one or more of trehalose, sucrose, lactose, and dextran; the alcohol is any one or more of isopropanol, methanol, and ethanol.
[0020] The coating buffer may also include a preservative with a mass percentage concentration of 0.01-0.1%. The preservative is any one or more of sodium azide, PC300, potassium sorbate, and Krovin300M.
[0021] The present application also provides a method for preparing an immunochromatographic test strip for quantitative detection of CRP, wherein the CRP-specific antibody is coated with the above-mentioned coating buffer to form a detection strip. When the sample passes through the detection line, the reduced glutathione contained in the detection line interacts with the CRP in the sample, thereby improving the detection effect.
[0022] The preferred preparation method comprises the following steps: S1, applying CRP-specific antibody A coupled to fluorescent microspheres and quality control antibody A coupled to fluorescent microspheres to a conjugate pad; S2, coating CRP-specific antibody B on a reaction membrane using a coating buffer as described in any one of claims 1 to 6 to form a detection zone; coating quality control antibody B on a reaction membrane to form a quality control zone; S3, assembling a sample pad, a conjugate pad prepared in step S1, a reaction membrane prepared in step S2, and a water-absorbing pad to a bottom plate to obtain a test strip; wherein steps S1 and S2 are not restricted in order.
[0023] Among them, since the quality control strip is a combination of the quality control antibody and the quality control antigen, and has nothing to do with the combination of the CRP antigen and antibody, the coating solution used for coating the quality control antibody B can be the above-mentioned coating buffer, or it can be a coating solution commonly used in the art. However, the coating solution basic formula used for the same test strip is close to the effect, so it is more preferred to use a coating solution similar to the coating buffer formula used in the test strip to coat the quality control antibody B. For example, the formula of the coating buffer used in the test strip is phosphate buffer, trehalose, isopropanol, sodium azide and reduced glutathione, then the coating solution formula used in the quality control strip can be phosphate buffer, trehalose, isopropanol and sodium azide.
[0024] The specific preparation steps of the immunochromatographic test strip for quantitative detection of CRP are preferably as follows: S1, activating the fluorescent microspheres, and then coupling the activated fluorescent microspheres with CRP-specific antibody A and quality control antibody A, respectively, to obtain CRP-specific antibody A-coupled fluorescent microspheres and quality control antibody A-coupled fluorescent microspheres; using coupling storage solution to re-dissolve the CRP-specific antibody A-coupled fluorescent microspheres and the quality control antibody A-coupled fluorescent microspheres and then spray them onto the conjugate pad; S2. Use the above-mentioned coating buffer to dilute the CRP-specific antibody B and then coat it on the reaction membrane to form a detection zone; use a commercially available coating solution or the above-mentioned coating buffer to coat the quality control antibody B on the reaction membrane to form a quality control zone.
[0025] S3, assembling the sample pad, the conjugate pad prepared in step S1, the reaction membrane prepared in step S2, and the water absorbent pad on the bottom plate in order from top to bottom, and connecting them with each other, wherein the detection band is located on the side close to the conjugate pad, so as to obtain a test strip; There is no order restriction for steps S1 and S2.
[0026] More preferably, the specific preparation steps of the immunochromatographic test strip for quantitative detection of CRP are as follows: S1-1, take 1 ml of the washed fluorescent microsphere solution with a solid content of 1%, ultrasonically treat for 30-60 seconds, successively add NHS solution with a concentration of 5-20 mg / mL and EDC solution with a concentration of 5-20 mg / mL, and the volume ratio of NHS solution to fluorescent microsphere solution is 1: (30-100), the volume ratio of EDC solution to fluorescent microsphere solution is 1: (50-200), and the volume ratio of EDC solution, NHS solution and fluorescent microspheres are the same or different; then incubate for 20-60 minutes, centrifuge and discard the supernatant, then add borate buffer with a concentration of 0.01-0.05 mol / L, the volume ratio of buffer to fluorescent microsphere solution is 1: (0.5-2), and ultrasonically treat until there is no precipitate in the solution to obtain an activated fluorescent microsphere solution; S1-2, add CRP-specific antibody A to the activated fluorescent microsphere solution at a ratio of 0.05-1.5 mg / mL, mix well, incubate for 2-5 hours, add BSA solution with a mass percentage concentration of 0.1-1% after completion, the volume of BSA solution and the mass ratio of CRP-specific antibody A are (0.2-0.6 ml): 1 mg, continue to incubate for 0.5-2 hours, centrifuge after completion, discard the supernatant, wash 2-3 times, and re-dissolve the washed microspheres with coupling storage solution to obtain CRP-specific antibody A coupled fluorescent microsphere solution; The quality control antibody A is prepared into a quality control antibody A-coupled fluorescent microsphere solution by the same method as S1-2; Spray CRP-specific antibody A-coupled fluorescent microsphere solution and quality control antibody A-coupled fluorescent microsphere solution onto the conjugate pad; S2. Use the above-mentioned coating buffer to dilute the CRP-specific antibody B to 0.5-1.5 mg / L, coat it on the reaction membrane, and then dry it at 50-60°C for 65-80 hours to form a detection band; use a commercially available coating solution or the above-mentioned coating buffer to dilute the quality control antibody B to 0.5-1.5 mg / L, coat it on the reaction membrane, and then dry it at 50-60°C for 65-80 hours to form a quality control band; S3-1. Prepare a sample pad treatment solution containing 0.05-0.2% bovine serum albumin and 2-8% trehalose by mass fraction. 2 The ratio of 200 μm to 200 μm was spread on the glass fiber and fully soaked, drained, and dried at 35-40°C for 12-20h to obtain a sample pad; S3-2, assembling the sample pad, the conjugate pad prepared in step S1, the reaction membrane prepared in step S2, and the water absorbent pad to the bottom plate in sequence from top to bottom, and connecting them with each other, wherein the detection band is located on the side close to the conjugate pad, to obtain a test strip; There is a sequence between step S1-1 and step S1-2, but there is no sequence restriction between step S1 as a whole and step S2.
[0027] In the above preparation method, the coupling storage solution can be prepared by mixing 0.01 mol / L trishydroxyaminomethane buffer, 5% trehalose by mass and 1% BSA by mass, with a pH value of 7.4. Commercially available coupling storage solutions can also be used.
[0028] In the present application, the quality control antibody can be an antibody known in the art, such as goat anti-chicken IgY, etc. The NHS solution used is an aqueous solution of N-hydroxysuccinimide, and the EDC solution is an aqueous solution of 1-ethyl-(3-dimethylaminopropyl)carbodiimide. BSA is bovine serum albumin.
[0029] In step S1-1, the fluorescent microsphere solution is an externally purchased commodity, and the commodity properties with different solid contents can be purchased according to needs, and can also be diluted to different solid contents according to needs.
[0030] In the present application, the reaction membrane may be a membrane known in the art, such as a nitrocellulose membrane. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0032] Figure 1 This is a linear relationship diagram of the test results of the biochemical reactor in Example 3 of the present invention (Example 2, all sample values); Figure 2 This is a linear relationship diagram of the test results of the biochemical reactor in Example 3 of the present invention (Comparative Example 2, all sample values); Figure 3 This is a linear relationship diagram of the test results of the biochemical reactor in Example 3 of the present invention (Example 2, sample value below 10 mg / L); Figure 4 This is a linear relationship diagram of the test results of the biochemical reactor in Example 3 of the present invention (Comparative Example 2, sample values below 10 mg / L). DETAILED DESCRIPTION
[0033] In order to enable those skilled in the art to better understand the technical solutions in this application, the technical solutions in the embodiments of this application will be clearly and completely described below. Obviously, the described embodiments are only part of the embodiments of this application, not all of them. Based on the embodiments in this application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.
[0034] Example 1 Coating Buffer Buffer: phosphate buffer, 0.02 mol / L; Carbohydrate: trehalose, mass fraction 5%; Alcohols: isopropanol, mass fraction 1%; Preservative: sodium azide, mass fraction 0.05%; Reduced glutathione, mass fraction 0.1%; The above raw materials are mixed well to obtain.
[0035] Comparative Example 1 The reagents and concentrations were the same as in Example 1, except that reduced glutathione was not added.
[0036] Example 2 Immunochromatographic test strip for quantitative detection of CRP S1-1, take 1 ml of the washed fluorescent microsphere solution with a solid content of 1%, ultrasonically treat for 30 seconds, add 10 μL of a 10 mg / L NHS solution and a 10 mg / L EDC solution, incubate on a rotary mixer for 30 minutes, centrifuge and discard the supernatant, then add 1 ml of a 0.05 mol / L borate buffer, and ultrasonically treat until there is no precipitate in the solution to obtain an activated fluorescent microsphere solution; S1-2, add 0.1 mg of CRP-specific antibody A to the activated fluorescent microsphere solution, mix well, and incubate for 3 hours. After completion, add 50 μL of 0.5% BSA solution by mass percentage, and continue incubation for 1 hour. After completion, centrifuge, discard the supernatant, and wash twice with ultrapure water. The washed microspheres are re-dissolved with 1 ml of coupling storage solution to obtain CRP-specific antibody A-coupled fluorescent microsphere solution, which is stored at 4°C; The coupling storage solution includes 0.01 mol / L tris(hydroxyaminomethane) buffer, 5% trehalose by mass and 1% BSA by mass, and the pH value of the coupling storage solution is 7.4; The quality control antibody was prepared into a quality control antibody A (sheep anti-chicken IgY) coupled fluorescent microsphere solution by the same method as S1-2, and then the CRP-specific antibody A coupled fluorescent microsphere solution and the quality control antibody A coupled fluorescent microsphere solution were sprayed onto the conjugate pad. S2. The above-mentioned CRP-specific antibody B and quality control antibody B (chicken IgY) were diluted to 1.0 mg / L using the coating buffer of Example 1, and then coated on the nitrocellulose membrane by spraying with a film sprayer to form a detection band (T line) and a quality control band (C line), and then dried at 55°C for 72 hours and stored dry.
[0037] S3-1. Prepare a sample pad treatment solution containing 0.1% bovine serum albumin and 5% trehalose by mass. Add the sample pad treatment solution at 0.05 mL / cm 2 The ratio of 20% to 20% was spread on the glass fiber and fully soaked, drained, and dried at 37℃ for 16h. After drying, it was cut into 16mm*300mm size with a chopper to obtain the sample pad, and then stored in an aluminum foil bag with desiccant and sealed.
[0038] S3-2. Stick the sample pad, conjugate pad, nitrocellulose membrane and absorbent paper on the PVC base plate in order from top to bottom, and connect with each other. The detection band is located on the side close to the conjugate pad. Cut them into membrane strips of appropriate width evenly according to experimental requirements. After being encapsulated, they can be used for clinical sample testing.
[0039] Comparative Example 2 The process and parameters are the same as those in Example 2, except that the coating buffer prepared in Comparative Example 1 is used in step S2.
[0040] Test strip performance test 1. Preparation of sample diluent Weigh 8g Nacl, 0.2g Kcl, 1.44g Na2HPO4, and 0.24g KH2PO4 powder, dissolve in 800mL water, adjust the pH to 7.4, add 2g surfactant S9, make up to 1000mL with ultrapure water, filter and store at room temperature.
[0041] 2. C-reactive protein reference test A C-reactive protein reference was taken and tested using the test strips of Example 2 and Comparative Example 2 to compare the difference in linear range between the coating buffers of Example 1 and Comparative Example 1.
[0042] The test values were 0.5, 1.0, 9.8, 30.6, 50.7, 71.9, 90.5, and 104.3 mg / L. Take the prepared test strips and test each concentration 5 times on the two systems. Dilute the sample 200 times with the sample diluent, immediately take 80uL and drop it on the test strips, and read the results after 3 minutes of reaction.
[0043] The results of the embodiment are shown in Table 1. The results of the comparative example are shown in Table 2: Table 1 Test results of Example 2
[0044] Table 2 Comparative Example 2 Test Results
[0045] From the above experimental results, it can be seen that when testing the same batch of reference products, the high value linear range of the coating buffer modified in Example 1 is comparable to that of the unmodified coating buffer in Comparative Example 1, but the precision is better than that of the unmodified coating buffer. When the sample concentration is less than 1 mg / L, the test results of the unmodified sample diluent in Comparative Example 1 are difficult to meet the requirements, while the coating buffer system modified in Example 1 has a higher sensitivity and can meet the detection requirements.
[0046] 3. Biochemical reactor test 5000 test strips of Example 2 and Comparative Example 2 were prepared, and 35 clinical samples with concentration values evenly distributed in the linear range were taken and tested by Hitachi biochemical reactor. Each sample was tested twice to verify the clinical relevance of the two systems. The test method was the same as the test method in the second item. The results are shown in Table 3: Table 3 Biochemical reactor test results
[0047] According to the results in Table 3, since 10 mg / L is the reference value of CRP for determining whether a patient has inflammation, it is of great clinical significance. Therefore, the test results of all sample values and the test results of sample values below 10 mg / L are plotted separately, as shown in the figure below. Figures 1 to 4 shown.
[0048] From Table 3 and Figures 1 to 4 The results show that, in parallel comparisons with a large number of test strips, the correlation between the low-value part of the concentration below 10 mg / L of Comparative Example 2 and Example 2 is better, and the test accuracy of the concentration below 1 mg / L is higher. For high-value samples with severe inflammation, the improved Example 2 better reduces sample interference, has a smaller degree of discreteness, and has better overall performance.
[0049] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A coating buffer for an immunochromatographic test strip for quantitative detection of CRP, characterized in that: include: Buffer, sugars, alcohols, reduced glutathione.
2. The coating buffer according to claim 1, characterized in that The mass percentage concentration of reduced glutathione is 0.05-0.5%.
3. The coating buffer according to claim 1, characterized in that The buffer concentration is 0.01-0.1 mol / L; The mass percentage concentration of sugars is 0.5-5%; The mass percentage concentration of alcohols is 0.1-2%.
4. The coating buffer according to any one of claims 1 or 3, characterized in that The buffer is any one of tris-hydroxyaminomethane buffer, 4-hydroxyethylpiperazineethanesulfonic acid, phosphate buffer, and borate buffer; The sugar is any one or more of trehalose, sucrose, lactose and dextran; The alcohol is any one or more of isopropanol, methanol and ethanol.
5. The coating buffer according to any one of claims 1 to 3, characterized in that It also includes a preservative with a mass percentage concentration of 0.01-0.1%.
6. The coating buffer according to claim 5, characterized in that The preservative is any one or more of sodium azide, PC300, potassium sorbate, and Krovin300M.
7. A method for preparing an immunochromatographic test strip for quantitative detection of CRP, characterized in that: The detection band is formed by coating the CRP-specific antibody using the coating buffer described in any one of claims 1 to 6.
8. The preparation method according to claim 7, characterized in that: The following steps are involved: S1, applying CRP-specific antibody A coupled to fluorescent microspheres and quality control antibody A coupled to fluorescent microspheres to the conjugate pad; S2. Coating the CRP-specific antibody B on the reaction membrane using the coating buffer according to any one of claims 1 to 6 to form a detection zone; The quality control antibody B is coated on the reaction membrane to form a quality control band; S3, assembling the sample pad, the binding pad prepared in step S1, the reaction membrane prepared in step S2, and the water absorbent pad onto the bottom plate to obtain a test strip; There is no order restriction for steps S1 and S2.
9. The preparation method according to claim 8, characterized in that: In step S2, the CRP-specific antibody B is diluted to 0.5-1.5 mg / L using the coating buffer according to any one of claims 1-6, coated on the reaction membrane, and then dried at 50-60° C. for 65-80 h.
10. An immunochromatographic test strip for quantitative detection of CRP prepared by the preparation method according to any one of claims 7 to 9.
Citation Information
Patent Citations
Rapid quantitative detection kit for human anti-liver-kidney microsomal antibody
CN106501522A
Myocardial enzyme composite quality control material
CN110031638A
Preparation method of detection test strip for immunochromatography
CN112526137A
Hypersensitive C-reactive protein fluorescence immunochromatography determination kit and preparation method thereof
CN116482376A
Immunological detection reagent, detection method using the immunological detection reagent, and manufacturing method of the reagent
JP2004184125A
